查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933307

全球顱內動脈瘤市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Intracranial Aneurysm Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 請詢問到貨日

價格

顱內動脈瘤市場成長因素

由於腦血管疾病盛行率的上升、早期診斷意識的增強以及微創神經血管治療技術的快速發展，全球顱內動脈瘤市場正經歷穩定成長。該市場規模在2025年達到17.4億美元，預計從2026年的18.7億美元成長至2034年的29.5億美元，預測期內年複合成長率（CAGR）為5.90%。憑藉強大的醫療基礎設施、積極的研究活動以及先進動脈瘤治療設備的高普及率，北美在2025年佔據了43.70%的市場佔有率，成為全球主導市場。

市場概覽

顱內動脈瘤（腦動脈瘤）是指腦血管壁薄弱導致的血管膨脹，呈球狀。動脈瘤破裂可導致嚴重的內出血，危及生命。治療方案包括顯微外科夾閉術和微創血管內手術，例如栓塞術、支架置入術和血流導向裝置。患者和醫療專業人員對這些治療方法的認識不斷提高，顯著推動了全球對顱內動脈瘤治療設備的需求。

根據腦動脈瘤基金會（2023年）的資料，美國約有 670萬人患有未破裂的腦動脈瘤，凸顯了需要診斷和治療的患者群體龐大。

新冠疫情的影響

由於選擇性神經血管手術減少以及醫療器械供應鏈中斷，新冠疫情對顱內動脈瘤市場產生了負面影響。疫情期間手術量的下降導致市場成長放緩。然而，隨著醫院服務的逐步恢復以及延遲的神經血管介入手術的實施，疫情後市場趨於穩定。

市場趨勢

影響市場的關鍵趨勢是微創手術越來越受歡迎。傳統的開顱手術和動脈瘤夾閉術正逐漸被血管內治療技術所取代，例如栓塞術和血流導引裝置，這些技術可以縮短恢復時間並降低手術風險。血流導向裝置的技術進步已將其應用範圍從複雜動脈瘤擴展到中小尺寸病變，刺激了醫療器材製造商的採用率和創新。

市場成長驅動因素

全球腦動脈瘤發生率的不斷上升是市場成長的主要驅動因素。磁振造影血管攝影（MRA）和3D血管攝影等先進影像診斷技術的進步提高了早期檢出率，導致尋求治療的患者人數不斷增加。此外，公共和私人機構對動脈瘤研究的大力支持也加速了創新。研究經費和長期臨床研究推動下一代治療設備的研發，這些設備具有更高的安全性和有效性。

在日本等國家，動脈瘤破裂的高風險促使早期篩檢計畫的進行，並增加了對動脈瘤治療器械的需求。

限制因子

儘管技術不斷進步，誤診和高昂的治療費用仍然是主要挑戰。治療破裂動脈瘤的成本遠高於治療未破裂動脈瘤。此外，發展中地區認知度低、缺乏標準化的診斷指南以及醫療基礎設施不足，導致診斷延遲，阻礙了市場的廣泛普及。

細分市場分析

依產品類型劃分，動脈瘤治療器械在2026年將佔據44.39%的市場佔有率，這主要得益於彈簧圈、夾子、血流導引裝置和血管內治療器械的高普及率。按動脈瘤類型劃分，囊狀動脈瘤是最常見的診斷類型，預計到2026年將佔 90.91%的市場佔有率。依終端用戶劃分，醫院將憑藉其技術精湛的專家和先進的神經血管治療設施，在2026年佔據 72.19%的市場佔有率，成為市場主導力量。

區域洞察

到2025年，北美市場規模達到 7.6億美元，這得益於強有力的宣傳活動、微創手術的早期應用以及積極的研發活動。歐洲緊隨其後，這主要得益於歐盟資助的研究計畫和許多創新新創公司。亞太地區預計將以最高的年複合成長率成長，這主要歸功於印度和中國等國家較高的疾病負擔、不斷擴大的醫療保健覆蓋範圍以及較低的手術成本。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要外科手術數（2026年）
  • 主要公司新產品發表數量
  • 關鍵趨勢：併購、商業合作
  • 顱內動脈瘤治療設備的技術進步
  • COVID-19 的影響市場

第5章 全球顱內動脈瘤市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 動脈瘤治療器械
      • 動脈瘤夾
      • 動脈瘤彈簧圈
      • 血管內治療器械
      • 血流導向裝置
    • 栓塞器械
      • 閉塞導管
      • 栓塞劑
    • 抽吸器械
      • 抽吸導管
      • 血栓切除器械
    • 入路器械
      • 微導管
      • 導絲
    預測：依類型
    • 囊狀動脈瘤
    • 梭形動脈瘤
    • 真菌性動脈瘤
  • 市場分析、洞察與預測：依最終用戶
    • 醫院
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：依地區
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美顱內動脈瘤市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 美國各州
    • 加拿大

第7章 歐洲顱內動脈瘤市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第8章 亞太地區顱內動脈瘤市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 亞太其他地區

第9章 拉丁美洲顱內動脈瘤市場分析動脈瘤市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第10章 中東與非洲顱內動脈瘤市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2026）
  • 公司簡介
    • Medtronic
    • B. Braun SE
    • Integra LifeSciences
    • MicroPort Scientific Corporation
    • Stryker
    • Johnson & Johnson Services, Inc.
    • Terumo Corporation（MicroVention Inc.）
    • Evasc Neurovascular Enterprises
    • Penumbra, Inc.
Product Code: FBI109526

Growth Factors of intracranial aneurysm Market

The global intracranial aneurysm market is witnessing steady growth due to the rising prevalence of cerebrovascular diseases, increasing awareness of early diagnosis, and rapid advancements in minimally invasive neurovascular treatment technologies. The market was valued at USD 1.74 billion in 2025 and is projected to grow from USD 1.87 billion in 2026 to USD 2.95 billion by 2034, registering a CAGR of 5.90% during the forecast period. North America dominated the market with a 43.70% share in 2025, supported by strong healthcare infrastructure, active research initiatives, and high adoption of advanced aneurysm treatment devices.

Market Overview

An intracranial or cerebral aneurysm is a balloon-like dilation of blood vessels in the brain caused by weakened vessel walls. If ruptured, it can lead to severe internal bleeding and can be life-threatening. Treatment options include microsurgical clipping and minimally invasive endovascular procedures such as coiling, stenting, and flow diversion. Increasing awareness among patients and healthcare providers regarding these treatment approaches is significantly boosting demand for intracranial aneurysm devices globally.

According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the U.S. live with an unruptured brain aneurysm, highlighting the large patient pool requiring diagnosis and treatment.

Impact of COVID-19

The COVID-19 pandemic negatively affected the intracranial aneurysm market due to reduced elective neurovascular procedures and disruptions in the supply chain of medical devices. A decline in procedure volumes during the pandemic led to slower market growth. However, the gradual resumption of hospital services and delayed neurovascular interventions helped the market regain stability post-pandemic.

Market Trends

A major trend shaping the market is the growing preference for minimally invasive procedures. Traditional craniotomy and clipping methods are increasingly being replaced by endovascular techniques such as coiling and flow diversion, which reduce recovery time and procedural risks. Technological advancements in flow diverters have expanded their use from complex aneurysms to small and medium-sized lesions, driving higher adoption and encouraging innovation among device manufacturers.

Market Growth Drivers

The increasing prevalence of cerebral aneurysms globally is a key driver of market growth. Advanced imaging technologies such as magnetic resonance angiography and 3D angiography have improved early detection rates, increasing the number of patients seeking treatment. Additionally, strong support from public and private organizations for aneurysm research is accelerating innovation. Research grants and long-term clinical studies are enabling the development of next-generation therapeutic devices with improved safety and efficacy.

Countries such as Japan show a higher risk of aneurysm rupture, which has led to early screening programs and increased demand for aneurysm treatment devices.

Restraining Factors

Despite technological progress, misdiagnosis and high treatment costs remain significant challenges. Treating ruptured aneurysms is substantially more expensive than managing unruptured cases. Moreover, limited awareness, lack of standardized diagnostic guidelines, and inadequate healthcare infrastructure in developing regions contribute to delayed diagnosis, restricting broader market penetration.

Segmentation Analysis

By product type, aneurysm therapeutic devices dominated the market with a 44.39% share in 2026, driven by high adoption of coils, clips, flow diverters, and intravascular devices. Based on aneurysm type, saccular aneurysms accounted for 90.91% of the market in 2026, as they are the most commonly diagnosed form. By end-user, hospitals led the market with a 72.19% share in 2026, owing to the availability of skilled professionals and advanced neurovascular treatment facilities.

Regional Insights

North America generated USD 0.76 billion in 2025, driven by strong awareness programs, early adoption of minimally invasive procedures, and robust R&D activity. Europe followed, supported by EU-funded research initiatives and innovation-driven startups. Asia Pacific is expected to grow at the highest CAGR, due to a high disease burden, expanding healthcare access, and lower surgical costs in countries such as India and China.

Competitive Landscape

The market is highly consolidated, with Stryker, Medtronic, and Terumo Corporation leading globally. These companies are focused on acquisitions, partnerships, and new product launches to strengthen their portfolios. Emerging players are also investing heavily in R&D to establish their presence in the neurovascular devices market.

Conclusion

The global intracranial aneurysm market is poised for consistent growth, expanding from USD 1.74 billion in 2025 to USD 2.95 billion by 2034, driven by rising prevalence of cerebral aneurysms, growing preference for minimally invasive treatments, and continuous technological advancements. While challenges such as misdiagnosis and high treatment costs persist, increasing research funding, improved diagnostic capabilities, and expanding healthcare infrastructure are expected to support sustained market growth throughout the forecast period.

Segmentation By Product Type

  • Aneurysm Therapeutic Devices
    • Clips
    • Coils
    • Intravascular Devices
    • Flow Diverter
  • Embolization Devices
    • Occlusion Catheters
    • Embolic Agent
  • Aspiration Devices
    • Aspiration Catheter
    • Clot Retrieval Device
  • Access Devices
    • Micro Catheter
    • Guidewire

By Type

  • Saccular aneurysm
  • Fusiform aneurysm
  • Mycotic aneurysm

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, Type, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Product Type, Type, End-User, and Country)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Product Type, Type, End-User, and Country)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Type, End-User, and Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Type, End-User, and Country)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Surgical Procedures, 2026
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Technological Advancement in Intracranial Aneurysm Devices
  • 4.5. Impact of COVID-19 on the Market

5. Global Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Aneurysm Therapeutic Devices
      • 5.1.1.1. Clips
      • 5.1.1.2. Coils
      • 5.1.1.3. Intravascular Devices
      • 5.1.1.4. Flow Diverter
    • 5.1.2. Embolization Devices
      • 5.1.2.1. Occlusion Catheters
      • 5.1.2.2. Embolic Agent
    • 5.1.3. Aspiration Devices
      • 5.1.3.1. Aspiration Catheter
      • 5.1.3.2. Clot Retrieval Device
    • 5.1.4. Access Devices
      • 5.1.4.1. Micro Catheter
      • 5.1.4.2. Guidewire
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Saccular aneurysm
    • 5.2.2. Fusiform aneurysm
    • 5.2.3. Mycotic aneurysm
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Aneurysm Therapeutic Devices
      • 6.1.1.1. Clips
      • 6.1.1.2. Coils
      • 6.1.1.3. Intravascular Devices
      • 6.1.1.4. Flow Diverter
    • 6.1.2. Embolization Devices
      • 6.1.2.1. Occlusion Catheters
      • 6.1.2.2. Embolic Agent
    • 6.1.3. Aspiration Devices
      • 6.1.3.1. Aspiration Catheter
      • 6.1.3.2. Clot Retrieval Device
    • 6.1.4. Access Devices
      • 6.1.4.1. Micro Catheter
      • 6.1.4.2. Guidewire
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Saccular aneurysm
    • 6.2.2. Fusiform aneurysm
    • 6.2.3. Mycotic aneurysm
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Aneurysm Therapeutic Devices
      • 7.1.1.1. Clips
      • 7.1.1.2. Coils
      • 7.1.1.3. Intravascular Devices
      • 7.1.1.4. Flow Diverter
    • 7.1.2. Embolization Devices
      • 7.1.2.1. Occlusion Catheters
      • 7.1.2.2. Embolic Agent
    • 7.1.3. Aspiration Devices
      • 7.1.3.1. Aspiration Catheter
      • 7.1.3.2. Clot Retrieval Device
    • 7.1.4. Access Devices
      • 7.1.4.1. Micro Catheter
      • 7.1.4.2. Guidewire
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Saccular aneurysm
    • 7.2.2. Fusiform aneurysm
    • 7.2.3. Mycotic aneurysm
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia pacific Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Aneurysm Therapeutic Devices
      • 8.1.1.1. Clips
      • 8.1.1.2. Coils
      • 8.1.1.3. Intravascular Devices
      • 8.1.1.4. Flow Diverter
    • 8.1.2. Embolization Devices
      • 8.1.2.1. Occlusion Catheters
      • 8.1.2.2. Embolic Agent
    • 8.1.3. Aspiration Devices
      • 8.1.3.1. Aspiration Catheter
      • 8.1.3.2. Clot Retrieval Device
    • 8.1.4. Access Devices
      • 8.1.4.1. Micro Catheter
      • 8.1.4.2. Guidewire
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Saccular aneurysm
    • 8.2.2. Fusiform aneurysm
    • 8.2.3. Mycotic aneurysm
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Rest of Asia Pacific

9. Latin America Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Aneurysm Therapeutic Devices
      • 9.1.1.1. Clips
      • 9.1.1.2. Coils
      • 9.1.1.3. Intravascular Devices
      • 9.1.1.4. Flow Diverter
    • 9.1.2. Embolization Devices
      • 9.1.2.1. Occlusion Catheters
      • 9.1.2.2. Embolic Agent
    • 9.1.3. Aspiration Devices
      • 9.1.3.1. Aspiration Catheter
      • 9.1.3.2. Clot Retrieval Device
    • 9.1.4. Access Devices
      • 9.1.4.1. Micro Catheter
      • 9.1.4.2. Guidewire
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Saccular aneurysm
    • 9.2.2. Fusiform aneurysm
    • 9.2.3. Mycotic aneurysm
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Aneurysm Therapeutic Devices
      • 10.1.1.1. Clips
      • 10.1.1.2. Coils
      • 10.1.1.3. Intravascular Devices
      • 10.1.1.4. Flow Diverter
    • 10.1.2. Embolization Devices
      • 10.1.2.1. Occlusion Catheters
      • 10.1.2.2. Embolic Agent
    • 10.1.3. Aspiration Devices
      • 10.1.3.1. Aspiration Catheter
      • 10.1.3.2. Clot Retrieval Device
    • 10.1.4. Access Devices
      • 10.1.4.1. Micro Catheter
      • 10.1.4.2. Guidewire
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Saccular aneurysm
    • 10.2.2. Fusiform aneurysm
    • 10.2.3. Mycotic aneurysm
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. B. Braun SE
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Integra LifeSciences
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. MicroPort Scientific Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Stryker
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Johnson & Johnson Services, Inc.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Terumo Corporation (MicroVention Inc.)
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Evasc Neurovascular Enterprises
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Penumbra, Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 3: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 4: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 5: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 6: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 7: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: Global Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 9: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 10: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 11: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 12: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 13: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 14: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 15: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 16: North America Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 17: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 18: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 19: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 20: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 21: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 22: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 23: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Europe Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 27: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 28: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 29: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 30: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 31: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 32: Asia Pacific Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 33: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 34: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 35: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 36: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 37: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 38: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 39: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 40: Latin America Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 42: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aneurysm Therapeutic Devices, 2021-2034
  • Table 43: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Embolization Devices, 2021-2034
  • Table 44: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Aspiration Devices, 2021-2034
  • Table 45: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Access Devices, 2021-2034
  • Table 46: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 47: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 48: Middle East & Africa Intracranial Aneurysm Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Intracranial Aneurysm Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034
  • Figure 2: Global Intracranial Aneurysm Market Value Share (%), by Product Type, 2026 & 2034
  • Figure 3: Global Intracranial Aneurysm Market Forecast (USD billion), by Aneurysm Therapeutic Devices, 2021-2034
  • Figure 4: Global Intracranial Aneurysm Market Forecast (USD billion), by Embolization Devices, 2021-2034
  • Figure 5: Global Intracranial Aneurysm Market Forecast (USD billion), by Aspiration Devices, 2021-2034
  • Figure 6: Global Intracranial Aneurysm Market Forecast (USD billion), by Access Devices, 2021-2034
  • Figure 7: Global Intracranial Aneurysm Market Value Share (%), by Type, 2026 & 2034
  • Figure 8: Global Intracranial Aneurysm Market Value Share (%), by End-user, 2026 & 2034
  • Figure 9: Global Intracranial Aneurysm Market Value (USD billion), by Region, 2026 & 2034
  • Figure 10: North America Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 11: North America Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 12: North America Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 13: North America Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 14: North America Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 15: North America Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 16: North America Intracranial Aneurysm Market Value (USD billion), By Country, 2026 & 2034
  • Figure 17: North America Intracranial Aneurysm Market Value Share (%), By Country, 2026
  • Figure 18: Europe Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 19: Europe Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 20: Europe Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 21: Europe Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 22: Europe Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 23: Europe Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 24: Europe Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 25: Europe Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 26: Asia Pacific Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 27: Asia Pacific Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 28: Asia Pacific Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 29: Asia Pacific Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 30: Asia Pacific Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 31: Asia Pacific Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 32: Asia Pacific Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 33: Asia Pacific Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 34: Latin America Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 35: Latin America Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 36: Latin America Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 37: Latin America Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 38: Latin America Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 39: Latin America Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 40: Latin America Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 41: Latin America Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 42: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 43: Middle East & Africa Intracranial Aneurysm Market Value Share (%), by Product Type, 2026
  • Figure 44: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), by Type, 2026 & 2034
  • Figure 45: Middle East & Africa Intracranial Aneurysm Market Value Share (%), by Type, 2026
  • Figure 46: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 47: Middle East & Africa Intracranial Aneurysm Market Value Share (%), by End-user, 2026
  • Figure 48: Middle East & Africa Intracranial Aneurysm Market Value (USD billion), By Country/ Sub-region, 2026 & 2034
  • Figure 49: Middle East & Africa Intracranial Aneurysm Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 50: Global Intracranial Aneurysm Market Share (%), By Company, 2026